Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line

Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected individuals are currently being explored, including approaches based on CRISPR-Cas gene editing. Extinction of all infectious HIV provirus in infected T-cell cultures was previously achieved when cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ye, Jeeninga, Rienk E., Klaver, Bep, Berkhout, Ben, Das, Atze T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705111/
https://www.ncbi.nlm.nih.gov/pubmed/34960730
http://dx.doi.org/10.3390/v13122461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705111/
https://www.ncbi.nlm.nih.gov/pubmed/34960730
http://dx.doi.org/10.3390/v13122461

Ejemplares similares